A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: favourite (50), preference (97)

Atezolizumab(1680-28days)

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab (1680mg-28 days) Indication • This p
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description
Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication • Ipi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

InP RIVAC (66) cytarabine etoposide ifosfamide rituximab

Description
Chemotherapy Protocol LYMPHOMA CYTARABINE-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVAC) 66 years and above Inpatie
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVAC-66-cytarabine-etoposide-ifosfamide-rituximab.pdf

InP RIVAC (65) cytarabine etoposide ifosfamide rituximab

Description
Chemotherapy Protocol LYMPHOMA CYTARABINE-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVAC) 65 years and below Inpatie
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVAC-65-cytarabine-etoposide-ifosfamide-rituximab.pdf

BEACOPP escalated

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-PREDNISOLONEPROCARBAZINE-VINCRIST
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BEACOPP-escalated.pdf

BEACOPDac escalated

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DACARBAZINE-DOXORUBICIN-ETOPOSIDEPREDNISOLONE-VINCRISTINE (BEACOPDac Escalated) Regimen • Lymphoma – BEACO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BEACOPDac-escalated.pdf

Cyclophosphamide Topotecan v1.1

Description
Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-TOPOTECAN Regimen Sarcoma – Cyclophosphamide-Topotecan Indication Advanced Ewings sar
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Topotecan-v1.1.pdf

Z-DEX dexamethasone idarubicin ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA Z-DEX-DEXAMETHASONE-IDARUBICIN Regimen Multiple Myeloma – Z-DEX-Dexamethasone-Idarubicin Indication Fir
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Z-DEX-dexamethasone-idarubicin-ver1.pdf

Pembrolizumab_400mg skin

Description
Chemotherapy Protocol SKIN CANCER Pembrolizumab (400mg) Regimen • Skin – Pembrolizumab (400mg) Indication • Pembrolizumab is rec
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Pembrolizumab-400mg.pdf

Pembrolizumab_200mg skin

Description
Regimen Chemotherapy Protocol SKIN CANCER Pembrolizumab (200mg) • Skin – Pembrolizumab (200mg) Indication • Pembrolizumab is rec
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Pembrolizumab-200mg.pdf
271 to 280 of 404
Previous … 26 27 28 29 30 … Next